175
CONCLUSION : This modified liposomal doxorubicin regimen results in less toxicity ( stomatitis , hand - foot syndrome ) than the standard FDA - approved dose schedule .
 Chemical: doxorubicin; Disease: toxicity; Disease: stomatitis; Disease: hand - foot syndrome
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: doxorubicin; Disease: toxicity; Disease: stomatitis; Disease: hand - foot syndrome